Showing results (31-40 of 139) with videos related to
Sort By:
Pageof 14
American Journal of Clinical Pathology|June 1, 2005
Type I interferon-associated recruitment of cytotoxic lymphocytes: a common mechanism in regressive melanocytic lesionsJoerg Wenzel, Barbara Bekisch, Manfred Uerlich, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 15, 2024
Downregulation of MHC-I on Melanoma Cells and Decreased CD8+ T-Cell Infiltration Are Associated With Metastatic Spread and Resistance to ImmunotherapyMiriam Mengoni, Felix O Mahlo, Evelyn Gaffal, et al.Academic Radiology|June 18, 2023
Subcutaneous Fat Abundance and Density Are Associated with an Enhanced Response to Immunotherapy in Metastatic Melanoma: A Retrospective Cohort StudyMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.Pigment Cell & Melanoma Research|July 24, 2010
Autochthonous primary and metastatic melanomas in Hgf-Cdk4 R24C mice evade T-cell-mediated immune surveillanceJennifer Landsberg, Evelyn Gaffal, Mira Cron, et al.The Journal of Investigative Dermatology|March 1, 2014
β-arrestin 2 inhibits proinflammatory chemokine production and attenuates contact allergic inflammation in the skinEvelyn Gaffal, Mira Jakobs, Nicole Glodde, et al.International Journal of Cancer|January 6, 2011
Neonatal UVB exposure accelerates melanoma growth and enhances distant metastases in Hgf-Cdk4(R24C) C57BL/6 miceEvelyn Gaffal, Jennifer Landsberg, Tobias Bald, et al.Journal of the American Academy of Dermatology|March 21, 2007
CXCR3-mediated recruitment of cytotoxic lymphocytes in lupus erythematosus profundusJoerg Wenzel, Julia Proelss, Andreas Wiechert, et al.The American Journal of Pathology|December 7, 2007
Indoleamine 2,3-dioxygenase (IDO): the antagonist of type I interferon-driven skin inflammation?Marina Scheler, Joerg Wenzel, Thomas Tüting, et al.Frontiers in Immunology|February 1, 2019
CD8<sup>+</sup>XCR1<sup>neg</sup> Dendritic Cells Express High Levels of Toll-Like Receptor 5 and a Unique Complement of Endocytic ReceptorsBen Wylie, James Read, Anthony C Buzzai, et al.Scientific Reports|April 12, 2016
A stochastic model for immunotherapy of cancerMartina Baar, Loren Coquille, Hannah Mayer, et al.Pageof 14